• Conventional chemotherapy often leads to systemic toxicity and limited therapeutic outcomes. • Nanoengineered drug delivery systems hold promise in overcoming immunosuppressive tumor microenvironment. • Integration of nanotechnology with conventional therapeutic modalities holds promise in overcoming current challenges.
No takes yet. Share an insight, caveat, or question.
Rengasamy et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: